Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the In-Situ Hybridization Market Expected to Be in 2029?

There has been a considerable expansion in the in-situ hybridization market size in the past few years. The forecast predicts a growth from $1.62 billion in 2024 to $1.78 billion in 2025, with a compound annual growth rate (CAGR) of 9.5%. The precedented expansion during the historical period can be linked to the increase in research and development activities, broader biopharmaceutical research, heightened governmental support for genomic research, a surge in demand for precision medicine therapies, and an uptick in the number of clinical trials employing ISH.

We are set to witness significant expansion in the in-situ hybridization market in the upcoming years. The market is projected to reach $2.53 billion by 2029, with a compound annual growth rate (CAGR) of 9.2%. This growth during the forecast period can be linked to several factors, including an increase in cancer cases, a rise in genetic disorders, a heightened demand for individualized medicine, an upsurge in the utilization of companion diagnostics, and an increased awareness of early disease diagnosis. The forecast period also foresees major trends such as progress in molecular diagnostics, technological improvements in ISH procedures, the availability of state-of-the-art ISH kits and reagents, a surge in demand for non-invasive diagnostic procedures, and advancements in fluorescence in-situ hybridization (FISH) technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24571&type=smp

What Are The Contributors To Demand In The In-Situ Hybridization Market?

The prognosticated amplification of cancer incidences is expected to stimulate the in-situ hybridization market’s expansion in the forthcoming years. Cancer, a disease characterized by uncontrolled growth and potential spread of abnormal cells, is on the rise due to extended lifespan, which provides additional time for genetic mutations to gather and for individuals to encounter factors triggering cancer. In-situ hybridization, referred to as ISH, is instrumental in managing cancer as it enables the identification of particular genetic anomalies within cancerous cells. This method is employed for precise diagnosing, prognosticating, and informing decisions regarding targeted therapies. As an illustration, the World Health Organization, based in Switzerland, projected in February 2024 that the number of new cancer cases is likely to surpass 35 million by 2050, an increase of 77% from the anticipated 20 million cases in 2022. As such, the escalating prevalence of cancer is set to augment the in-situ hybridization market’s growth.

What Segmentation Categories Are Included In The In-Situ Hybridization Market Analysis?

The in-situ hybridization market covered in this report is segmented –

1) By Product: Analytical Instruments, Kits And Reagents, Software And Services, Other Products

2) By Technology: Fluorescence In Situ Hybridization, Chromogenic In Situ Hybridization, Dual-Color In Situ Hybridization

3) By Application: Cancer Diagnosis, Cytogenetics, Developmental Biology, Infectious Diseases, Immunology, Other Applications

4) By End User: Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Contract Research Organizations, Pharmaceutical And Biotechnology Companies

Subsegments:

1) By Analytical Instruments: Fluorescence Microscopes, Brightfield Microscopes, Automated Slide Scanners, Hybridization Systems

2) By Kits And Reagents: DNA Probes, RNA Probes, Labeling Kits, Detection Reagents, Pretreatment Reagents

3) By Software And Services: Image Analysis Software, Data Management Software, Custom Probe Design Services, Sample Preparation Services

4) By Other Products: Slides And Coverslips, Storage Reagents, Hybridization Buffers, Control Probes

What Upcoming Trends Are Expected To Impact The In-Situ Hybridization Market Globally?

Leading entities in the realm of in-situ hybridization market are aiming at devising refined solutions, such as HER2 testing solutions, to predict the patient’s reaction to targeted therapies. The HER2 testing solutions serve as diagnostic instruments that detect the quantity and presence of HER2 protein in cancerous cells, which in turn assists in directing targeted treatment choices. For example, in December 2023, an Indian cancer diagnostic services firm, Cytelabs, introduced the dual in situ hybridization (DISH) examination for individuals with breast cancer. Granted approval by the US FDA, DISH technology signifies a major improvement in credible HER2 testing, which is significant for targeted treatment of breast cancer. It remarkably reduces the waiting span by delivering HER2 status outcomes within 24 to 48 hours, thereby reducing the anxiety levels of patients and their near ones. By supplying reliable results swiftly, DISH facilitates immediate treatment arrangement and commencement. As HER2 status plays an integral part in determining prognosis and therapy, accurate and swift testing is indispensable for the apt evaluation of all invasive breast cancers.

Who Are The Top-Ranked Companies In The In-Situ Hybridization Market Today?

Major companies operating in the in-situ hybridization market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen NV, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Biocare Medical LLC, BioGenex Srl, Oxford Gene Technology Inc., BioDot Inc., Creative Biolabs, West Medica Produktions- und Handels GmbH, Empire Genomics LLC, Abnova Corporation, BioView Ltd., Advanced Cell Diagnostics Inc., BioCat GmbH, VERMICON AG, Bio SB Inc., Genemed Biotechnologies Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/in-situ-hybridization-global-market-report

How Is In-Situ Hybridization Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the in-situ hybridization market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-situ hybridization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24571&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model